MIZUSHIMA Taichi

J-GLOBAL         Last updated: Oct 9, 2019 at 21:15
 
Avatar
Name
MIZUSHIMA Taichi
Affiliation
Yokohama City University
Section
School of Medicine Medical Course , Obstetrics and Gynecology
Job title
Assistant Professor

Research Areas

 
 

Published Papers

 
The Role of Androgen Receptor Signaling in Ovarian Cancer.
Mizushima T, Miyamoto H.
Mizushima T, Miyamoto H.   8(2) 176   Feb 2019   [Refereed]
Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract
Ide H, Jiang G, Mizushima T, Fujita K, Inoue S, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H
Oncol Lett   17(1) 482-487   Jan 2019   [Refereed]
ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
Inoue S, Mizushima T, Ide H, Jiang G, Goto T, Nagata Y, Netto GJ, Miyamoto H.
Endocr Connect   7(12) 1397-1408   Dec 2018   [Refereed]
Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
Ide H, Inoue S, Mizushima T, Jiang G, Chuang KH, Oya M, Miyamoto H.
Mol Cancer Ther.   17(7) 1566-1574   Jul 2018   [Refereed]
Izumi K, Inoue S, Ide H, Fujita K, Mizushima T, Jiang G, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H.
Int J Urol.   25(5) 429-435   May 2018   [Refereed]
Inoue S, Mizushima T, Miyamoto H.
Mol Cell Endocrinol.   465 73-81   Apr 2018   [Refereed]
Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S, Ide H, Mizushima T, Jiang G, Netto GJ, Gotoh M, Miyamoto H.
Mol Cancer Ther.      Mar 2018   [Refereed]
Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.
Inoue S, Ide H, Fujita K, Mizushima T, Jiang G, Kawahara T, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H.
Int J Mol Sci.   18(3) 777   Mar 2018   [Refereed]
The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells.
Li P, Chen J, Kashiwagi E, Mizushima T, Han B, Inoue S, Ide H, Izumi K, Miyamoto H.
Br J Cancer.   118(3) 416-420   Feb 2018   [Refereed]
Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.
Kashiwagi E, Inoue S, Mizushima T, Chen J, Ide H, Kawahara T, Reis LO, Baras AS, Netto GJ, Miyamoto H.
Br J Cancer.   118(2) 213-223   Jan 2018   [Refereed]
Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment
Suzuki Y, Tokinaga-Uchiyama A, Mizushima T, Maruyama Y, Mogami T, Shikata N, Ikeda A, Yamamoto H, Miyagi E
BMC Cancer   18(1) 973   Oct 2018   [Refereed]
Expression of erythropoietin mRNA in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
Asano R, Matsukuma S, Mizushima T, Taguri M, Inada M, Fukui A, Suzuki Y, Miyagi Y, Miyagi E.
Fertil Steril.   in Press    2018   [Refereed]
ELK1 Promotes Urothelial Tumorigenesis in the Presence of an Activated Androgen Receptor
Inoue S, Ide H, Mizushima T, Jiang G, Kawahara T, Miyamoto H.
Am J Cancer Res.   in press    2018   [Refereed]
Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.
Kawahara T, Inoue S, Kashiwagi E, Chen J, Ide H, Mizushima T, Li Y, Zheng Y, Miyamoto H.
Am J Cancer Res.   7(10) 2041-2050   Oct 2017   [Refereed]
ZKSCAN3 expression in urothelial carcinoma of the upper urinary tract and its impact on patient outcomes.
Jalalizadeh M, Inoue S, Fujita K, Ide H, Mizushima T, Yamaguchi S, Fushimi H, Nomura N, Miyamoto H.
Integr Cancer Sci Therap.   4(3) 1-4   Jun 2017   [Refereed]
Androgen receptor activation: a prospective therapeutic target for bladder cancer?
Mizushima T, Tirador KA, Miyamoto H.
Expert Opin Ther Targets.   21(3) 249-257   Mar 2017   [Refereed][Invited]
Inoue S, Mizushima T, Fujita K, Meliti A, Ide H, Yamaguchi S, Fushimi H, Netto GJ, Nonomura N, Miyamoto H.
Hum Pathol.   64 83-90   Jan 2017   [Refereed]
Kawahara T, Inoue S, Fujita K, Mizushima T, Ide H, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H.
Transl Oncol.   10(3) 318-327   Jan 2017   [Refereed]
Aberrant Nuclear Localization of aPKCλ/ι is Associated With Poorer Prognosis in Uterine Cervical Cancer.
Tokinaga-Uchiyama A*, Mizushima T*, Akimoto K, Nagashima Y, Nakaya M, Ohashi K, Kubota K, Sasaki K, Maruyama Y, Kato H, Hirahara F, Miyagi E, Ohno S, Asai-Sato M.
Int J Clin Exp Pathol.   in press    2017   [Refereed]
Kashiwagi E, Fujita K, Yamaguchi S, Fushimi H, Ide H, Inoue S, Mizushima T, Reis LO, Sharma R, Netto GJ, Nonomura N, Miyamoto H.
Cancer Biol Ther.   17(11) 1188-1196   Nov 2016   [Refereed]
Kawahara T, Inoue S, Ide H, Kashiwagi E, Ohtake S, Mizushima T, Li P, Li Y, Zheng Y, Uemura H, Netto GJ, Ishiguro H, Miyamoto H.
Oncotarget.   7(33) 53599-53610   Aug 2016   [Refereed]
Mizushima T, Asai-Sato M, Akimoto K, Nagashima Y, Taguri M, Sasaki K, Nakaya MA, Asano R, Tokinaga A, Kiyono T, Hirahara F, Ohno S, Miyagi E.
Int J Gynecol Pathol.   35(2) 106-117   Mar 2016   [Refereed]
Asano R, Asai-Sato M, Miyagi Y, Mizushima T, Koyama-Sato M, Nagashima Y, Taguri M, Sakakibara H, Hirahara F, Miyagi E.
Am J Obstet Gynecol.   213(2) 119e1-8   Aug 2015   [Refereed]
Yoshihama Y, Izumisawa Y, Akimoto K, Satoh Y, Mizushima T, Satoh K, Chida K, Takagawa R, Akiyama H, Ichikawa Y, Kunisaki C, Inayama Y, Endo I, Nagashima Y, Ohno S.
Cancer Sci.   104(2) 259-265   Feb 2013   [Refereed]